当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析

昆药集团

(600422)

  

流通市值:108.93亿  总市值:108.93亿
流通股本:7.57亿   总股本:7.57亿

昆药集团(600422)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润2.50亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益677108.32万元,未分配利润357302.38万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1265778.88万元,负债588670.56万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入3,351,347,279.451,608,452,032.428,401,447,233.375,457,454,882.94
营业总成本3,100,213,351.061,490,477,668.687,550,203,664.565,001,893,407.76
其他经营收益
营业利润299,803,982.41148,463,945.82927,546,633.87486,847,070.18
利润总额298,940,268.97149,103,911.43934,570,238.35497,506,100.63
净利润249,920,820.76113,552,441.59751,220,665.56390,513,080.86
每股收益
其他综合收益1,987,515.851,281,044.33-3,926,635.37-987,127.81
综合收益总额251,908,336.61114,833,485.92747,294,030.19389,525,953.05
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计8,635,256,590.098,680,727,395.488,555,000,337.247,554,757,129.88
非流动资产:
非流动资产合计4,022,532,237.034,023,796,766.214,056,366,796.332,466,934,727.32
资产总计12,657,788,827.1212,704,524,161.6912,611,367,133.5710,021,691,857.2
流动负债:
流动负债合计4,861,855,581.84,751,158,437.545,490,858,868.243,952,199,593.24
非流动负债:
非流动负债合计1,024,850,060.871,092,264,663.29374,240,690.39357,220,211.51
负债合计5,886,705,642.675,843,423,100.835,865,099,558.634,309,419,804.75
所有者权益(或股东权益):
归属于母公司股东权益合计5,226,959,645.615,345,426,198.415,253,648,545.415,532,501,840.76
股东权益合计6,771,083,184.456,861,101,060.866,746,267,574.945,712,272,052.45
负债和股东权益合计12,657,788,827.1212,704,524,161.6912,611,367,133.5710,021,691,857.2
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计3,986,161,434.831,707,090,079.828,660,369,482.985,324,279,969.78
经营活动现金流出小计3,767,330,478.481,846,536,508.557,852,303,842.285,107,938,942.71
经营活动产生的现金流量净额218,830,956.35-139,446,428.73808,065,640.7216,341,027.07
投资活动产生的现金流量:
投资活动现金流入小计1,294,842,286.96626,227,207.713,155,459,063.772,296,641,569.89
投资活动现金流出小计2,657,025,967.731,669,948,028.733,069,431,061.472,401,360,351.99
投资活动产生的现金流量净额-1,362,183,680.77-1,043,720,821.0286,028,002.3-104,718,782.1
筹资活动产生的现金流量:
筹资活动现金流入小计1,253,539,493.46953,621,441.382,876,676,610.63512,656,962.4
筹资活动现金流出小计1,099,931,735.21826,712,667.753,004,666,678.18785,429,670.37
筹资活动产生的现金流量净额153,607,758.25126,908,773.63-127,990,067.55-272,772,707.97
汇率变动对现金及现金等价物的影响1,028,421.1235,093.62987,451.2-219,445.44
现金及现金等价物净增加额-988,716,545.05-1,056,223,382.5767,091,026.65-161,369,908.44
期末现金及现金等价物余额1,145,207,866.721,077,701,029.272,133,924,411.771,204,567,494.93
补充资料:
现金及现金等价物的净增加额-988,716,545.05-767,091,026.65-
最新报告期:2025-08-19
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,唐庆雷,张云逸0.820.941.082025-08-19
东吴证券朱国广0.810.981.182025-08-18
开源证券余汝意,巢舒然0.831.001.212025-08-18
中泰证券孙宇瑶,祝嘉琦0.860.961.082025-08-17
TOP↑